↓ Skip to main content

Broccoli-Derived Sulforaphane and Chemoprevention of Prostate Cancer: From Bench to Bedside

Overview of attention for article published in Current Pharmacology Reports, April 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
4 X users
video
1 YouTube creator

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
70 Mendeley
Title
Broccoli-Derived Sulforaphane and Chemoprevention of Prostate Cancer: From Bench to Bedside
Published in
Current Pharmacology Reports, April 2015
DOI 10.1007/s40495-015-0034-x
Pubmed ID
Authors

Ali I. Amjad, Rahul A. Parikh, Leonard J. Appleman, Eun-Ryeong Hahm, Kamayani Singh, Shivendra V. Singh

Abstract

Sulforaphane (SFN) is a metabolic by product of cruciferous vegetables and is the biologically active phytochemical found in high concentrations in broccoli. It has been studied extensively for its anticancer efficacy and the underlying mechanisms using cell culture and preclinical models. The immediate precursor of SFN is glucoraphanin, a glucosinolate which requires metabolic conversion to SFN. SFN and other notable isothiocyanates, including phenethyl isothiocyanate and benzyl isothiocyanate found in various cruciferous vegetables, have also been implicated to have a chemopreventive role for breast, colon and prostate cancer. In-vitro and in-vivo anti-cancer activity of this class of compounds summarizing the past two decades of basic science research has previously been reviewed by us and others. The present review aims to focus specifically on SFN and its chemopreventive and antineoplastic activity against prostate cancer. Particular emphasis in this communication is placed on the current status of clinical research and prospects for future clinical trials with the overall objective to better understand the clinical utility of this promising chemopreventive nutraceutical in the context of mechanisms of prostate carcinogenesis.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 70 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 17 24%
Researcher 9 13%
Student > Master 6 9%
Student > Doctoral Student 5 7%
Other 4 6%
Other 10 14%
Unknown 19 27%
Readers by discipline Count As %
Medicine and Dentistry 12 17%
Pharmacology, Toxicology and Pharmaceutical Science 11 16%
Biochemistry, Genetics and Molecular Biology 8 11%
Agricultural and Biological Sciences 7 10%
Nursing and Health Professions 5 7%
Other 7 10%
Unknown 20 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2022.
All research outputs
#13,888,754
of 23,552,911 outputs
Outputs from Current Pharmacology Reports
#1
of 1 outputs
Outputs of similar age
#116,889
of 238,934 outputs
Outputs of similar age from Current Pharmacology Reports
#1
of 1 outputs
Altmetric has tracked 23,552,911 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1 research outputs from this source. They receive a mean Attention Score of 0.0. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 238,934 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them